Heron Neutron Medical Corp. is a healthcare technology company specializing in the development, manufacture, and integration of advanced medical equipment, with a primary focus on accelerator-based boron neutron capture therapy (AB-BNCT) systems. These solutions are designed for precise, effective cancer treatment, leveraging innovations in neutron source targets, accelerators, beam shaping, treatment control, and planning technologies. A distinguishing feature of Heron Neutron Medical Corp. is its position as a comprehensive solution provider: the company not only develops AB-BNCT devices but also integrates boron-containing therapeutic agents, enabling it to offer coordinated device-and-drug solutions to hospitals and research institutions. This integrated approach aims to improve clinical efficiency, enable precision targeting of tumors, lessen side effects compared to conventional treatments, and streamline the patient care process. Founded in 2016 and headquartered in Zhubei, Taiwan, Heron Neutron Medical Corp. continues to shape the market for cancer therapy devices, serving global healthcare providers while advancing the adoption of innovative cancer treatment modalities.